10x Genomics, Inc. TXG Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s change in lease liabilities?
- 10x Genomics, Inc. (TXG) reported change in lease liabilities of -$2.85M in Q1 2026.
- How has 10x Genomics, Inc.'s change in lease liabilities changed year-over-year?
- 10x Genomics, Inc.'s change in lease liabilities decreased by 8.5% year-over-year, from -$2.63M to -$2.85M.
- What is the long-term trend for 10x Genomics, Inc.'s change in lease liabilities?
- Over 3 years (2022 to 2025), 10x Genomics, Inc.'s change in lease liabilities has grown at a 17.1% compound annual growth rate (CAGR), from -$6.42M to -$10.31M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.